Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Current and Future of Biomarkers of Immune Related Adverse Events

Rheumatic Disease Clinics of North America(2024)10.1016/j.rdc.2024.01.004Source: DataRank Database

The Current and Future of Biomarkers of Immune Related Adverse Events is a research paper published in Rheumatic Disease Clinics of North America (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.80)OA: greenTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Sang T. Kim ORCID,William Bracamonte‐Baran

Live enrichment

PubMed:38670721 PMC:PMC11232920 OpenAlex:https://openalex.org/W4392703549

Rheumatology Research Foundation

Grant: 1012231

National Institutes of Health

Grant: K08AR079587

FWCI

1.80

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11232920/pdf/nihms-2002036.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0889857X24000048?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0889857X24000048?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11232920

Fields of Study

Cancer Immunotherapy and BiomarkersLymphoma Diagnosis and TreatmentImmune Cell Function and InteractionHumansAutoimmune DiseasesBiomarkersImmune Checkpoint InhibitorsNeoplasms

MeSH Terms

Immune Checkpoint InhibitorsAutoimmune DiseasesHumansNeoplasmsBiomarkers

Keywords

Adverse effectMedicineImmune systemIntensive care medicineImmunologyInternal medicineAutoantibodiesCytokinesChemokinesMicrobiomeImmune-related Adverse EventsImmune Checkpoint-inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being